Skip to content
★ Sign in to follow
CB

CardioVascular BioTherapeutics, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Levin Robert S, was filed 03 Apr 2008.

CardioVascular BioTherapeutics, Inc.: what insiders have been doing

Every trade that managers of CardioVascular BioTherapeutics, Inc. disclose to SEC (Form 4) is tracked on this page. CardioVascular BioTherapeutics, Inc. has had no insider filing for more than a year; the last one goes back to 18 August 2009.

Over the whole record (from 2006), the tally stands at 34 purchases and 196 sales.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
257
Thresholds
n/a
Buy Volume
€389,462
34 ops. · all time
Sell Volume
€3M
196 ops. · all time
Last declaration on 18 August 2009
Declarations257 total
  • ▼
    10% OwnerExecutives
    23,900 USD0SEC
    100,000 shares@ US$0.239Common StockSEC:0001314771-09-000011:0
  • ▼
    10% OwnerExecutives
    48,000 USD0SEC
    200,000 shares@ US$0.24Common StockSEC:0001314771-09-000011:1
  • ▼
    10% OwnerExecutives
    50,000 USD0SEC
    200,000 shares@ US$0.25Common StockSEC:0001314771-09-000011:2
  • ▼
    10% OwnerExecutives
    52,000 USD0SEC
    200,000 shares@ US$0.26Common StockSEC:0001314771-09-000011:3
  • ▼
    10% OwnerExecutives
    54,000 USD0SEC
    200,000 shares@ US$0.27Common StockSEC:0001314771-09-000011:4
  • ▼
    10% OwnerExecutives
    56,000 USD0SEC
    200,000 shares@ US$0.28Common StockSEC:0001314771-09-000011:5
  • ▼
    10% OwnerExecutives
    59,047 USD0SEC
    218,693 shares@ US$0.27Common StockSEC:0001314771-09-000011:6
  • ▼
    10% OwnerExecutives
    55,000 USD0SEC
    200,000 shares@ US$0.275Common StockSEC:0001314771-09-000011:7
  • ▼
    10% OwnerExecutives
    16,585 USD0SEC
    107,000 shares@ US$0.155Common StockSEC:0001314771-09-000010:0
  • ▼
    10% OwnerExecutives
    18,010 USD0SEC
    120,065 shares@ US$0.15Common StockSEC:0001314771-09-000010:1
  • ▼
    10% OwnerExecutives
    36,350 USD0SEC
    242,335 shares@ US$0.15Common StockSEC:0001314771-09-000010:2
  • ▼
    10% OwnerExecutives
    60,000 USD0SEC
    400,000 shares@ US$0.15Common StockSEC:0001314771-09-000010:3
  • ▼
    10% OwnerExecutives
    31,000 USD0SEC
    200,000 shares@ US$0.155Common StockSEC:0001314771-09-000010:4
  • ▼
    10% OwnerExecutives
    32,000 USD0SEC
    200,000 shares@ US$0.16Common StockSEC:0001314771-09-000010:5
  • ▼
    10% OwnerExecutives
    32,000 USD0SEC
    200,000 shares@ US$0.16Common StockSEC:0001314771-09-000010:6
  • ▼
    10% OwnerExecutives
    33,000 USD0SEC
    200,000 shares@ US$0.165Common StockSEC:0001314771-09-000010:7
  • ▼
    10% OwnerExecutives
    34,000 USD0SEC
    200,000 shares@ US$0.17Common StockSEC:0001314771-09-000010:8
  • ▼
    10% OwnerExecutives
    70,000 USD0SEC
    400,000 shares@ US$0.175Common StockSEC:0001314771-09-000010:9
  • ▼
    10% OwnerExecutives
    90,000 USD0SEC
    500,000 shares@ US$0.18Common StockSEC:0001314771-09-000010:10
  • ▼
    10% OwnerExecutives
    74,000 USD0SEC
    400,000 shares@ US$0.185Common StockSEC:0001314771-09-000010:11
  • ▼
    10% OwnerExecutives
    38,000 USD0SEC
    200,000 shares@ US$0.19Common StockSEC:0001314771-09-000010:12
  • ▼
    10% OwnerExecutives
    40,000 USD0SEC
    200,000 shares@ US$0.20Common StockSEC:0001314771-09-000010:13
  • ▼
    10% OwnerExecutives
    42,000 USD0SEC
    200,000 shares@ US$0.21Common StockSEC:0001314771-09-000010:14
  • ▼
    10% OwnerExecutives
    44,000 USD0SEC
    200,000 shares@ US$0.22Common StockSEC:0001314771-09-000010:15
  • ▼
    10% OwnerExecutives
    47,240 USD0SEC
    295,250 shares@ US$0.16Common StockSEC:0001314771-09-000009:0

25 of 257 declarations

About CardioVascular BioTherapeutics, Inc.

CardioVascular BioTherapeutics, Inc. is a company focused on developing biological therapies for the treatment of cardiovascular diseases. It is listed on the XNAS market.